<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08440</article-id><article-id pub-id-type="doi">10.7554/eLife.08440</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Network structure of brain atrophy in de novo Parkinson's Disease</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-33455"><name><surname>Zeighami</surname><given-names>Yashar</given-names></name><aff><institution content-type="dept">McConnell Brain Imaging Centre, Montreal Neurological Institute</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33456"><name><surname>Ulla</surname><given-names>Miguel</given-names></name><aff><institution content-type="dept">McConnell Brain Imaging Centre, Montreal Neurological Institute</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33457"><name><surname>Iturria-Medina</surname><given-names>Yasser</given-names></name><aff><institution content-type="dept">McConnell Brain Imaging Centre, Montreal Neurological Institute</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33458"><name><surname>Dadar</surname><given-names>Mahsa</given-names></name><aff><institution content-type="dept">McConnell Brain Imaging Centre, Montreal Neurological Institute</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41260"><name><surname>Zhang</surname><given-names>Yu</given-names></name><aff><institution content-type="dept">McConnell Brain Imaging Centre, Montreal Neurological Institute</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33459"><name><surname>Larcher</surname><given-names>Kevin Michel-Herve</given-names></name><aff><institution content-type="dept">McConnell Brain Imaging Centre, Montreal Neurological Institute</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33460"><name><surname>Fonov</surname><given-names>Vladimir</given-names></name><aff><institution content-type="dept">McConnell Brain Imaging Centre, Montreal Neurological Institute</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33461"><name><surname>Evans</surname><given-names>Alan C</given-names></name><aff><institution content-type="dept">McConnell Brain Imaging Centre, Montreal Neurological Institute</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33462"><name><surname>Collins</surname><given-names>Douglas Louis</given-names></name><aff><institution content-type="dept">McConnell Brain Imaging Centre, Montreal Neurological Institute</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-23764"><name><surname>Dagher</surname><given-names>Alain</given-names></name><aff><institution content-type="dept">McConnell Brain Imaging Centre, Montreal Neurological Institute</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country><email>alain.dagher@mcgill.ca</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-16662"><name><surname>Van Essen</surname><given-names>David C</given-names></name><role>Reviewing editor</role><aff><institution>Washington University in St Louis</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>07</day><month>09</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e08440</elocation-id><supplementary-material><ext-link xlink:href="elife-08440-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>30</day><month>04</month><year>2015</year></date><date date-type="accepted"><day>05</day><month>09</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Zeighami et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Zeighami et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>We mapped the distribution of atrophy in Parkinson's Disease (PD) using MRI and clinical data from 232 PD patients and 117 controls from the Parkinson's Progression Markers Initiative. Deformation based morphometry and independent component analysis identified PD-specific atrophy in the midbrain, basal ganglia, basal forebrain, medial temporal lobe, and discrete cortical regions. The degree of atrophy reflected clinical measures of disease severity. The spatial pattern of atrophy demonstrated overlap with intrinsic networks present in healthy brain, as derived from functional MRI. Moreover, the degree of atrophy in each brain region reflected its functional and anatomical proximity to a presumed disease epicenter in the substantia nigra, compatible with a trans-neuronal spread of the disease. These results support a network-spread mechanism in PD. Finally, the atrophy pattern in PD was also seen in healthy aging, where it also correlated with the loss of striatal dopaminergic innervation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: For the Parkinson's Progression Markers Initiative (PPMI) database (www.ppmi-info.org/data)Each participating PPMI site received approval from a local research ethics committee before study initiation, and obtained written informed consent from all subjects participating in the study.For the resting state fMRI data collected in our lab, We acquired resting state fMRI in 51 healthy, right-handed volunteers.The experimental protocol was reviewed and approved by Research Ethics Board of Montreal Neurological Institute. All subjects gave informed consent.</p></fn></fn-group></back></article>